G&W Laboratories

Pharmaceutical | December 26, 2016

Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596, “Kubota Pharma”), a clinical-stage ophthalmology company committed to translating innovation into a diverse portfolio of drugs and devices to preserve and restore vision for millions of people worldwide, and SBI Holdings, Inc. (“SBI”), a financial services and asset management company based in Japan, announced today the signing of a non-binding letter of intent (“LOI”) to establish a joint venture that will organize and manage special purpose...

ZME Science | December 21, 2016

US authorities have charged six companies of price fixing in the US, India, and Australia. Drugmakers Mylan, Heritage Pharmaceuticals, Teva Pharmaceutical USA and Citron Pharma are named in the lawsuit alongside India’s Aurobindo Pharma and Australia’s Mayne Pharmaceuticals....

SUN PHARMA | October 19, 2016

International Centre for Genetic Engineering and Biotechnology (ICGEB) and Sun Pharma (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, Sun Pharmaceutical Industries Ltd and includes its subsidiaries or associate companies) today announced their new collaboration for development of a dengue vaccine, targeted against all the four serotypes of Dengue virus that cause disease in humans....

SUN PHARMA | June 08, 2016

As part of its plans to grow the Global Consumer Healthcare business, Sun Pharma will focus on Dermatology as the fourth engine of growth for its OTC business. As part of this growth strategy, the company today announced roll-out of its first dermatology product through the Global Consumer Healthcare business. Branded as Suncros, this is a sunscreen product, offering maximum protection from harmful UV rays till the inner layers of the skin....